Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted ...
Ahead of the event, dmg events hosted a press conference to highlight how the extended format addresses the surging demand ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
Hundreds of engineers are losing their jobs and leaving our shores due to infrastructure project delays, creating ...
In 2022 consumables contributed 58% of group revenue. We see the consumables revenue stream as more secure because it's protected from generic substitution until fiscal 2029, and we forecast these ...
Broad Institute to collaborate on flagship project tapping Illumina's new spatial technology At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning ...
Labour MP Kieran McAnulty wants a guarantee from the Government that Masterton ratepayers are not indirectly helping to plug ...
3d
News Medical on MSNGroundbreaking ALS platform trial accelerates research and drug testingAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed publication entitled: ...
A single structure overseen by the National Treasury will be established during the 2025/26 fiscal year to coordinate State ...
In individual stocks, Intel (NASDAQ: INTC) shares jumped in premarket U.S. trading on a Wall Street Journal report that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results